ABBV241206C255000
- 0.05
- 0.000.00%
AbbVie Newsroom
Why Is AbbVie Inc. (ABBV) Among the Dividend Kings You Should Consider?
AbbVie Inc. (ABBV) Citi's 2024 Global Healthcare Conference (Transcript)
SpaceX's $350 Billion Private Valuation Signals an IPO Is off the Table for Now
AbbVie To Present At Citi's 2024 Global Healthcare Conference; Webcast At 10:15 AM ET
Here Is What to Know Beyond Why AbbVie Inc. (ABBV) Is a Trending Stock
Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform -- Barrons.com
Satellos to Participate in Duchenne KOL Investor Webinar on December 4, 2024
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report?
With 73% Ownership in AbbVie Inc. (NYSE:ABBV), Institutional Investors Have a Lot Riding on the Business
Why AbbVie Inc. (ABBV) Is One of the Most Undervalued Pot Stocks to Buy?
Express News | The world's first ovarian cancer ADC drug has been approved domestically.
Unusual Options Activity: EDR, BBD and Others Attract Market Bets, EDR V/OI Ratio Reaches 174.3
EST Nov 26th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
(ABBV) - Analyzing AbbVie's Short Interest
Is AbbVie Inc. (ABBV) the Best Dividend Aristocrat Stock To Buy Right Now?
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Market Whales and Their Recent Bets on ABBV Options
Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference